Cannabis Bioscience International Holdings (CBIH) Notes Payables (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Notes Payables across 4 years of filings, most recently posting $111721.0 for Q1 2026.

• Notes Payables for Q1 2026 came in at $111721.0, changed N/A year-over-year; the trailing twelve-month figure through Feb 2026 was $111721.0 (changed N/A YoY), and the FY2025 annual result was $9182.0, changed N/A from the prior year.
• Notes Payables came in at $111721.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from $101.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $151267.0 in Q4 2023 to a low of $101.0 in Q4 2025.
• The 4-year median for Notes Payables is $9182.0 (2025), against an average of $57821.2.
• Across the five-year window, Notes Payables sank 98.52% in 2024 and slumped 94.35% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Notes Payables stood at $151267.0 in 2023, then tumbled by 98.52% to $2236.0 in 2024, then tumbled by 95.48% to $101.0 in 2025, then surged by 110514.85% to $111721.0 in 2026.
• The last three Notes Payables figures came in at $111721.0 (Q1 2026), $101.0 (Q4 2025), and $6363.0 (Q3 2025), per Business Quant data.